Drug treatment of Alzheimer's disease - a clinician's view point

Drug treatment of Alzheimer's disease - a clinician's view point

Bibliographic Details
Main Author:	Wilcock, G
Format:	Conference item
Published:	1991

Similar Items

Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)

Actual problems of atherosclerosis: point of view of clinician
by: R. S. Karpov
Published: (2003-03-01)

Drug resistance in tuberculosis: A clinician's view
by: Kamal Kishor Chopra
Published: (2020-01-01)

Treatment of the cholinergic impairment in Alzheimer's disease
by: Wilcock, G
Published: (1994)

Current approaches to the treatment of Alzheimer's disease.
by: Wilcock, G
Published: (1996)

Iatrogeny of Alzheimer′s disease: A view point
by: Manu Kothari, et al.
Published: (2016-01-01)

Treatment of Alzheimer's disease: future directions.
by: Wilcock, G, et al.
Published: (1996)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
by: Wilcock, G
Published: (2007)

Alzheimer’s disease: a mini-review for the clinician
by: Rishi S. Madnani
Published: (2023-06-01)

Detecting patients with Alzheimer's disease suitable for drug treatment: comparison of three methods of assessment.
by: Wilcock, G, et al.
Published: (1994)

Disease-modifying treatments for Alzheimer's disease: a perspective based on experience with R-Flurbiprofen.
by: Wilcock, G
Published: (2006)

Physical Exercise in New Health Concepts: A Clinician Point of View
by: Xinhao Li, et al.
Published: (2022-06-01)

Neurotrophins in Alzheimer's disease
by: Wilcock, G
Published: (2002)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
by: Wilcock, G, et al.
Published: (1993)

Assessing quality of life in dementia: a clinician's perspective
by: Wilcock, G
Published: (2002)

Alzheimer's disease--current issues.
by: Wilcock, G
Published: (1988)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
by: Wilcock, G
Published: (1990)

Hyperinsulinaemia and Alzheimer's disease.
by: Razay, G, et al.
Published: (1994)

Galantamine in Alzheimer's disease.
by: Razay, G, et al.
Published: (2008)

Biomarkers in Early Diagnosis and Early Stage Lung Cancer: The Clinician’s Point of View
by: Roberto Gasparri, et al.
Published: (2020-06-01)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
by: Kehoe, P, et al.
Published: (2007)

Age and Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1983)

Velnacrine for Alzheimer's disease.
by: Birks, J, et al.
Published: (2004)

Treating Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1995)

Bapineuzumab in Alzheimer's disease: where now?
by: Wilcock, G
Published: (2010)

The effects of galantamine treatment on caregiver time in Alzheimer's disease.
by: Sano, M, et al.
Published: (2003)

Bronchial asthma and gastroesophageal reflux disease: view of the clinician and pathophysiologist
by: Svetlana Vladimirovna Lyamina, et al.
Published: (2011-06-01)

The challenge of Alzheimer's disease--no longer a silent epidemic.
by: Wilcock, G
Published: (1988)

The olfactory bulbs in Alzheimer's disease.
by: Esiri, M, et al.
Published: (1984)

The increasing burden of Alzheimer disease.
by: Sadik, K, et al.
Published: (2003)

Asymmetry of pathology in Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1987)

THE ROLE OF GROWTH-FACTORS AND NEUROPEPTIDES IN ALZHEIMERS-DISEASE
by: Wilcock, G
Published: (1994)

Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.
by: Wilcock, G
Published: (1994)

Clinical interpretation and application of genetic tests in Alzheimer's disease
by: Wilcock, G
Published: (1999)

The metabolic syndrome and Alzheimer disease.
by: Razay, G, et al.
Published: (2007)

Issues in drug treatment for Alzheimer's disease.
by: Mcshane, R, et al.
Published: (1997)

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
by: Michalis Michailidis, et al.
Published: (2022-04-01)

Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers?
by: Wilcock, G
Published: (1994)

Will we have a drug for Alzheimer's disease by 2030? The view from pharma
by: Lovestone, S, et al.
Published: (2019)

Recent Alzheimer's disease research highlights.
by: Galasko, D, et al.
Published: (2012)